Bank of America Securities Maintains a Buy on CVS Health Corporation (CVS)

CVS Health Corporation (NYSE:CVS) is one of the best large cap value stocks to buy now. Bank of America Securities analyst Allen Lutz maintained a Buy rating on CVS Health Corporation (NYSE:CVS) on September 25 and set a price target of $89.00.

CVS Health Corporation (NYSE:CVS) reported $98.9 billion in total revenues for fiscal Q2 2025, up 8.4% compared to the prior year period.

GAAP diluted EPS for the quarter was $0.80, and adjusted EPS was $1.81. CVS Health Corporation (NYSE:CVS) also generated year-to-date cash flow from operations of $6.5 billion.

CVS Health Corporation (NYSE:CVS) is a health solutions company that operates in four segments: healthcare benefits, health services, pharmacy & consumer wellness, and corporate/other.

While we acknowledge the potential of CVS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.